All entries for: Ovid Therapeutics Inc.

March 18, 2026

Ovid Therapeutics Inc.

Neutral Outlook

New York, NY
1-50 employees

The current administration is pursuing policies to reduce regulations and expenditures across government agencies including at HHS, the FDA, the United States Centers for Medicare & Medicaid Services (“CMS”) and related agencies. These actions, presently directed by executive orders or memoranda from the Office of Management and Budget, may propose policy changes that create additional uncertainty for our business.

Scroll to Top